HUBUNGAN HIPERTENSI DERAJAT 1 DAN 2 PADA OBESITAS TERHADAP KOMPLIKASI ORGAN TARGET DI RSUP DR KARIADI SEMARANG - Diponegoro University | Institutional Repository (UNDIP-IR)

DAFTAR PUSTAKA

1. Rahajeng

E,

Tuminah,

Sulistyowati.

Prevalensi

Hipertensi

dan

Determinannya di Indonesia. Jakarta; Pusat Penelitian Biomedis dan
Farmasi Badan Penelitian Kesehatan Departemen Kesehatan RI, Jakarta;
2009.
2. Mansjoer, Arif . Kapita Selekta Kedokteran Jilid I : Nefrologi dan
Hipertensi Jakarta: Media Aesculapius FKUI. 2001;519-20.

3. Lilyasari O . Hipertensi Dengan Obesitas : Adakah Peran Endotelin – 1?
Jakarta : Departemen Kardiologi dan Kedokteran Vaskular, Fakultas
Kedokteran Universitas Indonesia Pusat Jantung Nasional, Harapan Kita:
Jurnal Kardiologi Indonesia; 2007.
4. Falaschetti E, Hingorani AD, Jones A, Charakida M, Finer N, Whincup P,
et al. Adiposity and cardiovascular risk factors in a large contemporary
population of prepubertal children. Eur Heart J, 2010; 31:3063-72.
5. P Palatini, F Saladini, L Mos, E Benetti, A Bortolazzi, S Cozzio. Obesity is a
strong determinant of hypertensive target organ damage in young-tomiddle-age patient. International Journal of Obesity. 2013.
6. Osuji CU, Nwaneli CU, Onwubere BJ, Onwubuya EI, Ahaneku GI.
Clinical Study Renal Function in Patients with Hypertension Associated
Congestive Cardiac Failure Seen in a Tertiary Hospital. International
Journal of Nephrology. 2012;3.

1

2

7. Adiwibowo T. Faktor faktor yang berhubungan dengan kondisi tekanan
darah sopir (studi prevalensi pada paguyuhan Rukun sentosa Semarang

tahun 2009). Semarang;2009.
8. Lionakis N, Mendrinos, Dimitrios, Sanidas, Elias, Favatas, Georgios
Georgopoulou, Maria. Hypertension in the elderly. World Journal of
Cardiology. 2012.
9. Agrina R, Sunarti Swastika, Haritama, Riyan. Kepatuhan Lansia Penderita
Hipertensi dalam Pemenuhan Diet Hipertensi. Jurnal Sorot.2010.
10. Dasar dasar Fisiologi Kardiovaskuler. Jakarta: EGC;1996.
11. Kuswardhani RT. Penatalaksanaan Hipertensi pada Lanjut Usia. Denpasar:
Divisi Geriatri Bagian Penyakit Dalam FK UNUD, RSUP Sanglah
Denpasar;2006.
12. Fauci AS, kasper, Dennis L et al. Harrison Manual Kedokteran Jilid Dua
Bagian Kardiologi, Tangerang Selatan; Karisma Publishing Group;2012.
13. Yogiantoro M. Hipertensi Esensial Buku Ajar Ilmu Penyakit Dalam Jilis
II. V ed. Jakarta: Internal Publishing Pusat Penerbitan Ilmu Penyakit
Dalam. 2009.
14. Dwiputra B. Hubungan Perilaku dengan Prevalensi Hipertensi pada
Masyarakat Kota Ternate Tahun 2008. Jakarta: Universitas
Indonesia;2009.
15. Balistreri CR, Caruso C, Candore G, The Role of ADIPOSE Tissue and
Adipokines in Obesity-Related Inflammatory Disease. Mediators of

Inflammation. 2010;3-5.

3

16. Sugondo S. Obesitas. Dalam: Sudoyo AW, Setiyohadi B, Alwi I,
Simadibrata M, Setiati S, editor. Buku Ajar Ilmu Penyakit Dalam. Jakarta:
Badan Penerbit Departemen Ilmu Penyakit Dalam FKUI; 2006: 1941-6.
17. Stelfox HT, Ahmed SB, Ribeiro RA, Gettings EM, Pomerantsev E,
Schmidt U. Hemodynamic monitoring in obese patients: the impact of
body mass index on cardiac output and stroke volume, Crit Care Med
2006; 34:1243-1246
18. Lambert GW, Straznicky NE, Lambert EA, Dixon JB, Schlaich MP.
Sympatethic nervous activation in obesity and the metabolic syndrome
causes: causes, consequences and therapeutic implications. Pharmacol
Ther 2010; 126:159-172
19. Lambert E, Sari CI, Dawood T, Nguyen J, McGrane M, Eikelis N, et al.
Sympathetic nervous system is associated with obesity-induced subclinical
organ damage in young adults. Hypertension. 2010; 56;351-358
20. Kim J, Montagnani M, Koh KK, Quon MJ. Reciprocal relationship
between insulin resistance and endothelial dysfunction. Circulation 2006.

113: 1888-1904.
21. Bastard JP, Jardel C, Delattre J, Hainque B, Bruckery E, Oberlin F.
Evidence for a link between adipose tissue interleukin-6 content and serum
C-reactive protein concentrations in obese subjects. Circulation.
1999;99:2221-2222
22. Frohlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, Boeing H,
Muche R, Brenner H, Koening W. Association between C-reactive protein

4

and features of the metabolic syndrome: a population-based study.
Diabetes Care. 2000;23:1835-1839
23. Pickering TG et al: Recommendations for blood pressure measurement in
humans and experimental animals. Part 1: Blood pressure measurement in
humans. A statement for professionals from the Subcommittee of
Professional and Public Education of the American Heart Association
Council on High Blood Pressure Research. Hypertension, 45:142,
2005[PMID: 15611362]
24. Sugiyanto E. Hipertensi dan Komplikasi Serebrovaskular. Cermin Dunia
Kedokteran. 2007(157):173-80.

25. Donald M. Lloyd-Jones M, ScM; Jane C. Evans, Dsc; Daniel Levy, MD.
Hypertension in adult across the age spectrum: current outcomes and
control in the community. Journal of American Medical Association.
2005;294(4):466-72.
26. Ong KL TA, Lam KS, Cheung BM. Gender difference in blood pressure
control and cardiovascular risk factors in Americans with diagnoses
hypertension. American Heart Association. 2008;51:1142-8.
27. Geriatri KK. Hipertensi dan Stroke pada Lansia. Panti Werdha Kristen
Hana: Fakultas Kedokteran Universitas Tarumanegara; 2012.
28. Wong TY, Mitchell P, Hypertensive Retinopathy. New England Journal of
Medicine. 2004;351(22):2310-7.

5

29. Kustini. Beberapa Faktor Risiko yang Berhubungan dengan Kejadian
Retinopati ( Studi Kasus di Semarang Eye Center RSI Sultan Agung
Semarang ) . Semarang: Universitas Muhamadiyah Semarang;2010.
30. Wong TY, Mcintosh, Rachel. Hypertensive Retinopathy signs as risk
indicators of cardiovascular morbidity and mortality. Oxford Journals
British Medical Bulletin. 2005;7374(1):57-70.

31. Chaniago LS. Penyakit Arteri Perifer pada Sindroma Metabolik. Medan:
Fakultas Kedokteran Universitas Sumatera Utara / RS H Adam Malik
Medan;2007.
32. Ayodele OE, Alebiosu CO, Salako BL, Awodein OG, Adigun AD. Target
organ damage and associated clinical conditions among Nigerians with
treated

hypertension.

Cardiovascular

Journal

Of

South

Africa.

2005;16(2):89-93.

33. Cheung Ning, Tien Y.Wong. Obesity and Eye Diseases.US National
Library of Medicine National Institutes of Health.2009
34. De jong, Verhave JC, Pinto-sietsma SJ, Hillege,Obesity and target organ
damage:the kidney. International journal of obesity. 2002

6

Lampiran 1. Analisis Univariat Karakteristik Data

Usia

Descriptives
Usia

K.OT
Ya

Tidak

Mean

95% Conf idence
Interv al f or Mean
5% Trimmed Mean
Median
Variance
Std. Dev iat ion
Minimum
Maximum
Range
Interquart ile Range
Skewness
Kurt osis
Mean
95% Conf idence
Interv al f or Mean
5% Trimmed Mean
Median
Variance
Std. Dev iat ion
Minimum

Maximum
Range
Interquart ile Range
Skewness
Kurt osis

Lower Bound
Upper Bound

Lower Bound
Upper Bound

Stat istic
59.27
56.46

Std. Error
1.413

62.09

59.52
60.00
153.648
12.395
16
84
68
13
-.351
.872
58.30
48.24

.274
.541
4.447

68.36
58.39
63.00

197.789
14.064
35
80
45
23
-.397
-.567

.687
1.334

7

Tests of Normality
a

Usia

K. OT
Ya
Tidak

Kolmogorov -Smirnov
St at ist ic
df
Sig.
.089
77
.200*
.204
10
.200*

St at ist ic
.974
.946

Shapiro-Wilk
df
77
10

*. This is a lower bound of the true signif icance.
a. Lillief ors Signif icance Correction

80

Usia

60

40
30

20

7

Ya

Tidak

K.OT

T-Test

Group Statisti cs

Usia

K. OT
Ya
Tidak

N
77
10

Mean
59.27
58.30

St d. Dev iation
12.395
14.064

St d. Error
Mean
1.413
4.447

Sig.
.122
.621

8

Independent Samples Test

Lev ene's Test f or
Equality of Variances
t-t est f or Equality of
Means

Usia
Equal v ariances
Equal v ariances
not assumed
assumed
.409
.524
.230
.208
85
10.894
.819
.839

F
Sig.
t
df
Sig. (2-tailed)
Mean Dif f erence
St d. Error Dif f erence
95% Conf idence Interv al
of the Dif f erence

Lower
Upper

.973

.973

4.229

4.666

-7.437
9.382

-9.310
11.255

9

Lampiran 2. Analisis bivariat
K.Otak * Hipertensi

Crosstab

K.
Otak

Ya

Tidak

Total

Count
Expected Count
% wit hin Hipertensi
% of Total
Count
Expected Count
% wit hin Hipertensi
% of Total
Count
Expected Count
% wit hin Hipertensi
% of Total

Hipertensi
Grade I
Grade II
3
16
5.0
14.0
13.0%
25.0%
3.4%
18.4%
20
48
18.0
50.0
87.0%
75.0%
23.0%
55.2%
23
64
23.0
64.0
100.0%
100.0%
26.4%
73.6%

Total
19
19.0
21.8%
21.8%
68
68.0
78.2%
78.2%
87
87.0
100.0%
100.0%

Chi-Square Tests

Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by -Linear
Association
N of Valid Cases

Value
1.417b
.803
1.536

1.401

df
1
1
1

1

Asy mp. Sig.
(2-sided)
.234
.370
.215

Exact Sig.
(2-sided)

Exact Sig.
(1-sided)

.378

.187

.237

87

a. Computed only f or a 2x2 table
b. 0 cells (.0%) hav e expected count less than 5. The minimum expected count is 5.
02.

10

Risk Esti mate
95% Conf idence
Interv al
Lower
Upper

Value
Odds Rat io f or K.
Otak (Y a / Tidak)
For cohort Hipertensi
= Grade I
For cohort Hipertensi
= Grade II
N of Valid Cases

.450

.118

1.717

.537

.178

1.616

1.193

.931

1.529

87

K.Mata * Hipertensi

Crosstab

K.
Mata

Ya

Tidak

Total

Count
Expected Count
% wit hin Hipertensi
% of Total
Count
Expected Count
% wit hin Hipertensi
% of Total
Count
Expected Count
% wit hin Hipertensi
% of Total

Hipertensi
Grade I
Grade II
1
8
2.4
6.6
4.3%
12.5%
1.1%
9.2%
22
56
20.6
57.4
95.7%
87.5%
25.3%
64.4%
23
64
23.0
64.0
100.0%
100.0%
26.4%
73.6%

Total
9
9.0
10.3%
10.3%
78
78.0
89.7%
89.7%
87
87.0
100.0%
100.0%

11

Chi-Square Tests

Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by -Linear
Association
N of Valid Cases

Value
1.212b
.493
1.418

1.198

df
1
1
1

1

Asy mp. Sig.
(2-sided)
.271
.483
.234

Exact Sig.
(2-sided)

Exact Sig.
(1-sided)

.435

.252

.274

87

a. Computed only f or a 2x2 table
b. 1 cells (25.0%) hav e expect ed count less than 5. The minimum expected count is 2.
38.

Risk Esti mate

Value
Odds Rat io f or K.
Mata (Y a / Tidak)
For cohort Hipertensi
= Grade I
For cohort Hipertensi
= Grade II
N of Valid Cases

95% Conf idence
Interv al
Lower
Upper

.318

.038

2.695

.394

.060

2.586

1.238

.945

1.621

87

K.Jantung * Hipertensi

12

Crosstab

K.Jantung

Ya

Tidak

Total

Count
Expected Count
% wit hin Hipertensi
% of Total
Count
Expected Count
% wit hin Hipertensi
% of Total
Count
Expected Count
% wit hin Hipertensi
% of Total

Hipertensi
Grade I
Grade II
17
37
14.3
39.7
73.9%
57.8%
19.5%
42.5%
6
27
8.7
24.3
26.1%
42.2%
6.9%
31.0%
23
64
23.0
64.0
100.0%
100.0%
26.4%
73.6%

Total
54
54.0
62.1%
62.1%
33
33.0
37.9%
37.9%
87
87.0
100.0%
100.0%

Chi-Square Tests

Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by -Linear
Association
N of Valid Cases

Value
1.863b
1.242
1.932

1.842

df
1
1
1

1

Asy mp. Sig.
(2-sided)
.172
.265
.165

Exact Sig.
(2-sided)

Exact Sig.
(1-sided)

.215

.132

.175

87

a. Computed only f or a 2x2 table
b. 0 cells (.0%) hav e expected count less than 5. The minimum expected count is 8.
72.

13

Risk Esti mate
95% Conf idence
Interv al
Lower
Upper

Value
Odds Rat io f or K.
Jantung (Y a / Tidak)
For cohort Hipertensi
= Grade I
For cohort Hipertensi
= Grade II
N of Valid Cases

2.068

.720

5.936

1.731

.760

3.946

.837

.657

1.067

87

K.Ginjal * Hipertensi

Crosstab

K. Ginjal

Ya

Tidak

Total

Count
Expected Count
% wit hin Hipertensi
% of Total
Count
Expected Count
% wit hin Hipertensi
% of Total
Count
Expected Count
% wit hin Hipertensi
% of Total

Hipertensi
Grade I
Grade II
4
18
5.8
16.2
17.4%
28.1%
4.6%
20.7%
19
46
17.2
47.8
82.6%
71.9%
21.8%
52.9%
23
64
23.0
64.0
100.0%
100.0%
26.4%
73.6%

Total
22
22.0
25.3%
25.3%
65
65.0
74.7%
74.7%
87
87.0
100.0%
100.0%

14

Chi-Square Tests

Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by -Linear
Association
N of Valid Cases

Value
1.032b
.542
1.089

1.020

df
1
1
1

1

Asy mp. Sig.
(2-sided)
.310
.462
.297

Exact Sig.
(2-sided)

Exact Sig.
(1-sided)

.407

.235

.313

87

a. Computed only f or a 2x2 table
b. 0 cells (.0%) hav e expected count less than 5. The minimum expected count is 5.
82.

Risk Esti mate

Value
Odds Rat io f or K.
Ginjal (Y a / Tidak)
For cohort Hipertensi
= Grade I
For cohort Hipertensi
= Grade II
N of Valid Cases

K.PDP * Hipertensi

95% Conf idence
Interv al
Lower
Upper

.538

.161

1.801

.622

.237

1.631

1.156

.899

1.487

87

15

Crosstab

K.
PDP

Ya

Tidak

Total

Count
Expected Count
% wit hin Hipertensi
% of Total
Count
Expected Count
% wit hin Hipertensi
% of Total
Count
Expected Count
% wit hin Hipertensi
% of Total

Hipertensi
Grade I
Grade II
1
8
2.4
6.6
4.3%
12.5%
1.1%
9.2%
22
56
20.6
57.4
95.7%
87.5%
25.3%
64.4%
23
64
23.0
64.0
100.0%
100.0%
26.4%
73.6%

Total
9
9.0
10.3%
10.3%
78
78.0
89.7%
89.7%
87
87.0
100.0%
100.0%

Chi-Square Tests

Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by -Linear
Association
N of Valid Cases

Value
1.212b
.493
1.418

1.198

df
1
1
1

1

Asy mp. Sig.
(2-sided)
.271
.483
.234

Exact Sig.
(2-sided)

Exact Sig.
(1-sided)

.435

.252

.274

87

a. Computed only f or a 2x2 table
b. 1 cells (25.0%) hav e expect ed count less than 5. The minimum expected count is 2.
38.

16

Lampiran 3. Spreadsheet
No
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38

No CM
C302492
C475476
C395455
C261345
C448892
C395205
C399076
C435412
C365542
C409762
C398370
C374149
C416629
C195635
C434494
C434354
C206314
C406601
C434484
C331241
C429571
C404311
C397478
C239482
C142585
C160185
B098496
C410656
C409025
C393849
C387868
C204117
C393849
C403277
C226895
C398779
C368694
C420423

Thn
2011
2014
2013
2011
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2014
2013
2013
2013
2013
2011
2013
2013
2013
2013
2009
2010
2013
2013
2013
2012
2012
2013
2012
2013
2012
2013
2011
2013

Sex
l
l
l
l
l
P
L
L
P
L
P
P
L
P
P
P
L
L
P
L
L
L
P
L
L
L
P
P
P
L
P
L
P
L
P
L
P
P

1
1
1
1
1
2
1
1
2
1
2
2
1
2
2
2
1
1
2
1
1
1
2
1
1
1
2
2
2
1
2
1
2
1
2
1
2
2

BB TB
80
155
80
156
75
150
76
151
75
155
90
160
70
150
95
165
70
151
68
150
67
145
72
155
65
145
79
154
82
157
80
154
75
154
70
148
70
145
90
168
80
150
80
150
72
145
69
151
100
175
80
152
72 155.5
75
152
81
165
91
170
85
168
95
175
90
172
80
150
70
148
81
165
85
165
65
148

BMI
Usia TS
TD
33.30
60 210 110
32.87
65 180 120
33.33
76 180 100
33.33
64 140 50
31.22
78 130 80
35.16
61 130 80
31.11
16 191 87
34.89
55 180 100
30.70
55 130 100
30.22
55 130 80
31.87
80 160 80
29.97
66 130 80
30.92
79 143 87
33.31
56 160 82
33.27
64 140 80
33.73
48 160 100
31.62
49 130 70
31.96
71 160 100
33.29
65 130 80
31.89
62 180 120
35.56
74 160 90
35.56
64 170 90
34.24
44 130 80
30.26
73 150 60
32.65
64 170 54
34.63
75 180 100
29.78
48 150 90
32.46
60 160 100
29.75
58 160 90
31.49
34 150 90
30.12
54 130 70
31.02
66 150 100
30.42
84 130 80
35.56
72 160 40
31.96
46 125 100
29.75
54 130 90
31.22
47 160 90
29.67
62 134 78

17

39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82

B350514
C109693
C426713
426183
C222368
C346758
A221818
C283598
B358658
C089758
C406747
C399066
C088775
C087135
C251178
C043336
B206374
C174065
C240526
C399076
C087756
C109116
B424996
C172006
C001206
C138586
B399066
C432209
C226809
C307989
C322789
C228339
C406123
B353603
C420423
C294773
C401973
C420793
C384362
C378212
C120412
C411512
C398370
C397320

2010
2013
2013
2013
2013
2013
2012
2013
2013
2013
2013
2013
2012
2010
2013
2013
2013
2011
2011
2013
2011
2010
2010
2011
2010
2010
2010
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
2013

P
P
P
L
L
P
P
L
L
L
P
L
L
P
P
L
P
P
P
L
L
P
P
P
P
L
L
P
P
L
L
P
P
P
P
P
L
L
P
P
L
P
P
P

2
2
2
1
1
2
2
1
1
1
2
1
1
2
2
1
2
2
2
1
1
2
2
2
2
1
1
2
2
1
1
2
2
2
2
2
1
1
2
2
1
2
2
2

69
80
82
75
65
90
85
82
83
80
75
71
78
82
80
90
80
71
65
68
69
81
82
85
88
85
80
70
82
81
75
65
78
71
65
80
75
81
64
75
72
80
80
75

152
150
163
149
145
168
168
162
165
155
153
151
165
165
162
175
158
148
148
150
151
165
167
165
166
161
154
152
165
161
155
149
163
158
148
165
156
165
145
158
155
165
165
155

29.86
35.56
30.86
33.78
30.92
31.89
30.12
31.25
30.49
33.30
32.04
31.14
28.65
30.12
30.48
29.39
32.05
32.41
29.67
30.22
30.26
29.75
29.40
31.22
31.93
32.79
33.73
30.30
30.12
31.25
31.22
29.28
29.36
28.44
29.67
29.38
30.82
29.75
30.44
30.04
29.97
29.38
29.38
31.22

63
58
64
83
56
69
74
43
56
66
60
64
45
45
46
76
54
35
55
76
64
52
40
80
40
56
60
68
54
64
51
56
55
60
62
60
70
62
44
57
40
50
80
44

160
130
160
160
140
140
150
150
140
160
150
180
190
130
168
150
140
140
180
191
140
160
140
190
180
200
140
150
180
160
160
150
170
140
156
156
130
140
140
160
120
140
170
140

70
70
90
90
120
90
70
100
100
100
80
90
100
75
75
90
70
70
110
87
70
100
80
100
90
120
100
80
90
80
100
100
110
100
71
71
80
60
90
100
90
100
70
70

18

83
84
85
86
87

No

B250071
C398401
C277694
C043336
B206374

2013
2013
2012
2013
2013

HT
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31

2
2
2
1
1
2
2
1
1
1
2
1
2
2
2
2
1
2
1
2
2
2
1
2
2
2
2
2
2
2
1

K.Otak
y
y

P
L
L
L
P

2 69
1 70
1 106
1 90
2 80

K.Mata
y

152
152
173
175
158

29.86
30.30
35.42
29.39
32.05

K.Jantung K.Ginjal

58
42
56
76
54

K.PDP
y

y
y
y

y
y
y
y
y
y

y

y
y
y
Y
Y
Y
Y
Y
Y
Y
y
y

y

y

Y
Y
Y
y
y
y
y
y
y
y

Y

y

y
Y
y

y

180 100
140 90
140 90
150 90
140 70

K.OT
y
y
y
y
y
y
y
y
y
y
y
y
y
y
y
y
y
y
y
y
y
y
y
y
y
y
y
y
y
y

19

32
33
34
34
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75

2
1
2
1
2
2
1
2
1
2
2
1
2
2
2
2
2
2
2
2
1
2
2
2
1
2
2
1
2
2
2
2
2
1
2
2
2
2
2
2
2
2
2
1

y

y
y

y
y

Y

Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y

y
y

y

y

y

y

y

y

Y

Y
Y

Y
Y
Y

Y
Y

Y
Y
Y
Y

Y

Y
Y
Y
Y
Y

Y
Y

Y
Y
Y
Y
Y
Y
Y

Y

Y
Y

Y
Y
Y

y
y
y
Y
y
y
y
y
y
y
y
y
y
y
y
y
y

Y
Y

Y
Y
Y
Y
Y
Y
Y
Y
Y
Y

20

76
77
78
79
80
81
82
83
84
85
86
87

2
1
2
1
2
2
2
2
1
2
2
2

Y
Y

Y

Y
Y

Y
Y
Y
Y
Y

Y
Y
Y

Y
Y

Lampiran 4. Ethical Clearance

Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y

21

22

Lampiran 5. Surat Ijin Penelitian

23

24

Lampiran 6. Biodata
Identitas
Nama

: Muhammad Riefky Putra Agusti

NIM

: 22010110110098

Tempat / tanggal lahir

: Bekasi, 17 September 1992

Jenis Kelamin

: Laki Laki

Alamat

: Jl. Bojong Sari 1 No 72 RT 1 RW 12, Kelurahan
Bojong Rawalumbu, Kecamatan Rawalumbu,
Bekasi Timur

Nomor HP

: 07877459768

E-mail

: tanyaknapa123@yahoo.com

Riwayat Pendidikan Formal
1.

SD

: 1998 Lulus tahun : 2004

2.

SMP

: 2004 Lulus tahun : 2007

3.

SMA

: 2008 Lulus tahun : 2010

4.

FK UNDIP

: Masuk tahun 2010

Keanggotan Organisasi
1. Badan Kelengkapan ROHIS BEM FK UNDIP Tahun 2012 s/d 2013

25